JOHN HAMER

Insider Reports History

Location
Research Triangle Park, NC
Signature
/s/ Tryn Stimart, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JOHN HAMER:

Company Role Class Num Shares Value Price $ Report Date Ownership
AbCellera Biologics Inc. Director Common Shares 14,605,761 $39,435,555 $2.70 31 Aug 2021 Indirect
AbCellera Biologics Inc. Director Common Shares 128,862 $347,927 $2.70 01 Sep 2021 Direct

Insider Reports Filed by JOHN HAMER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABCL AbCellera Biologics Inc. 31 Aug 2021 2 -$5,082,253 4 Director 02 Sep 2021, 18:12
ABCL AbCellera Biologics Inc. 18 Jun 2021 2 $0 4 Director, 10%+ Owner 22 Jun 2021, 18:39